High
54.100
Open
53.850
VWAP
53.64
Vol
9.42K
Mkt Cap
175.91M
Low
53.500
Amount
505.29K
EV/EBITDA(TTM)
5.67
Total Shares
3.53M
EV
92.93M
EV/OCF(TTM)
6.27
P/S(TTM)
4.59
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women’s health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. The Company’s products include BT-CATH, CVX-RIPE, CVX-RIPE, MUC-X, AROM-CO, DISPOSA-HOOD, DELTRAN PLUS, EPITOME and OptiMicro Electrosurgical Devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, and LUMIN. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
Show More
Valuation Metrics
The current forward P/E ratio for Utah Medical Products Inc (UTMD.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Utah Medical Products Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2024Q4
YoY :
-25.74%
9.16M
Total Revenue
FY2024Q4
YoY :
-25.71%
2.93M
Operating Profit
FY2024Q4
YoY :
-32.29%
2.90M
Net Income after Tax
FY2024Q4
YoY :
-27.12%
0.86
EPS - Diluted
FY2024Q4
YoY :
-44.14%
2.93M
Free Cash Flow
FY2024Q4
YoY :
+0.99%
58.12
Gross Profit Margin - %
FY2024Q4
35.68
FCF Margin - %
FY2024Q4
YoY :
-8.81%
31.69
Net Margin - %
FY2024Q4
YoY :
-17.71%
11.29
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
1.9K
Volume
1
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
2
8.6K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
UTMD News & Events
Events Timeline
2025-04-29 (ET)
2025-04-29
09:20:59
Utah Medical Products reports Q1 EPS 92c vs. $1.09 last year
2024-11-05 (ET)
2024-11-05
09:05:31
Utah Medical Products appoints Carrie Leigh to board of directors
2024-11-05
09:04:44
Utah Medical board raises quarterly cash dividend by 1.7% to 30.5c per share
Sign Up For More Events
Sign Up For More Events
News
6.5
04-01NASDAQ.COMTop Research Reports for Verizon, The Southern Co. & Blackstone
4.0
03-12NASDAQ.COMValidea Benjamin Graham Strategy Daily Upgrade Report - 3/12/2025
8.0
03-09TipRanksEx-Dividend Date Nearing for These 10 Stocks – Week of March 10, 2025
Sign Up For More News
People Also Watch
AFRI
Forafric Global PLC
7.840
USD
-1.01%
BYND
Beyond Meat Inc
2.280
USD
-2.56%
ONTF
ON24 Inc
4.850
USD
+2.54%
NREF
Nexpoint Real Estate Finance Inc
14.350
USD
+0.07%
HDSN
Hudson Technologies Inc
7.460
USD
-4.36%
PAL
Proficient Auto Logistics Inc
7.175
USD
-7.06%
DBI
Designer Brands Inc
3.300
USD
+0.30%
FOA
Finance of America Companies Inc
21.400
USD
+2.74%
JMSB
John Marshall Bancorp Inc
17.120
USD
-0.23%
ACRS
Aclaris Therapeutics Inc
1.260
USD
-3.82%
FAQ
What is Utah Medical Products Inc (UTMD) stock price today?
The current price of UTMD is 53.6 USD — it has decreased -0.5 % in the last trading day.
What is Utah Medical Products Inc (UTMD)'s business?
What is the price predicton of UTMD Stock?
What is Utah Medical Products Inc (UTMD)'s revenue for the last quarter?
What is Utah Medical Products Inc (UTMD)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Utah Medical Products Inc (UTMD)'s fundamentals?
How many employees does Utah Medical Products Inc (UTMD). have?